Liquid Biopsy Index

Non-Oncology Applications: 3 of 14

Transplant Monitoring

After a kidney, heart, liver, or lung transplant, one of the biggest long-term concerns is rejection. The recipient's immune system can recognize the donated organ as foreign and attack it. That process may begin before the person feels any symptoms, so transplant patients need ongoing monitoring.

A biopsy gives the clearest answer. A doctor removes a small piece of the transplanted organ with a needle and examines it under a microscope. The information is direct, but the procedure is invasive and carries a risk of bleeding. For a heart transplant, repeated biopsies can mean threading a device through a vein into the heart itself, again and again over the years.

Blood offers another way to look. The donated organ came from another person, so its DNA is genetically different from the recipient's. As cells in the transplanted organ die, some of their DNA enters the bloodstream. A laboratory can measure how much of all the cell-free DNA in the blood came from the donor. This is called donor-derived cell-free DNA.

A healthy transplanted organ turns over cells at a relatively steady rate, so donor-derived DNA usually stays low. If the organ is injured, more cells die and the level can rise. That change may show up before the patient notices symptoms or before standard blood tests of organ function become abnormal.

A high result does not tell you why the organ is injured. Rejection can raise it, but so can infection, drug toxicity, or damage from surgery. The result may therefore lead to more testing, sometimes including the same biopsy the blood test was meant to avoid. A persistently low result can be especially useful because it provides evidence that the organ is not being actively damaged and may help some patients avoid an invasive procedure.

Timing matters too. Levels are naturally high just after surgery because the organ has been injured during the operation, so clinicians have to wait for a useful baseline. Different organs also have different typical levels, which means the number has to be interpreted in the right context.

In this index: 1,136 of the classified papers and patents concern transplant monitoring.

This page explains what these tests are and how researchers use them. It is not medical advice, and it is not a guide to whether any test is right for you or for a patient. Talk to a clinician about testing decisions.